Theranos founder Elizabeth Holmes faces cross-examination
ABC News
The fraud trial of fallen Theranos founder Elizabeth Holmes is set to resume Tuesday with continued cross-examination of Holmes and possible expert psychological testimony
SAN FRANCISCO -- The fraud trial of fallen Theranos founder Elizabeth Holmes is set to resume Tuesday with continued cross-examination of Holmes and possible expert psychological testimony.
Holmes, 37, has pleaded not guilty to charges of defrauding investors and patients by failing to deliver on her promise to revolutionize health care with a technology that was supposed to be able to detect a wide range of diseases and other problems by testing just a few drops of blood.
She is charged with two counts of conspiracy to commit wire fraud and nine counts of wire fraud, which carry a maximum prison sentence of 20 years.
Her defense team has described her as a tireless worker who poured more than 15 years of her life into the pursuit of a faster, cheaper and less invasive way to test blood samples and screen for disease.
